Targeted Therapies in Blood Cancer

The "Targeted Therapies in Blood Cancer" session will spotlight the development and application of precision medicines for hematologic cancers. This session will feature discussions on monoclonal antibodies, small molecules, and other targeted drugs that offer promising alternatives to traditional treatments. Attendees will gain an understanding of the mechanisms and efficacy of these therapies in improving survival rates and reducing side effects.

Key Topics:

  • Small Molecule Inhibitors: Mechanisms and advancements in targeting signaling pathways in blood cancers.
  • Monoclonal Antibodies and Biologics: Emerging biologic agents and their role in targeted therapy.
  • Companion Diagnostics: The role of biomarkers in predicting response to targeted treatments.

    Related Conference of Targeted Therapies in Blood Cancer

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Targeted Therapies in Blood Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in